Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Promoter Buying (Off-Market)

Zydus Lifesciences Promoter Buying (Off-Market)

Zydus Lifesciences reported the transmission of 10,000 shares within its promoter group. The transaction reflects internal succession planning and does not change aggregate promoter control.

Source

NSE filing, NSE: ZYDUSLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Zydus Lifesciences Ltd: key numbers

Share price
₹1,175.50
Market cap
₹1,18,283 Cr
Revenue (annual)
₹27,148 Cr
Net profit (annual)
₹5,040 Cr
P/E (TTM)
26.2×Sector 46.1×
Promoter holding
75.01%+0.00% QoQ
FII holding
7.05%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zydus Lifesciences Ltd

All →
18:27 IST NSE
Partnership

Zydus Lifesciences Partnership

Zydus Lifesciences' division Zylidac Bio partnered with Prolific Machines to scale their next-generation biologics manufacturing platform for GMP production.

11:09 IST NSE
Regulatory Approval

Zydus Lifesciences Regulatory Approval

Zydus Lifesciences received USFDA approval for its Estradiol-Levonorgestrel Transdermal System ANDA, designated as a CGT. The product is eligible for 180-day exclusivity upon first commercial marketing.

Other promoter buying (off-market) announcements

All →